| Dr John Brooke Tourtelot, MD | |
|
455 Pinellas St, Clearwater, FL 33756-3354 | |
| (727) 461-8300 | |
| (727) 298-6924 |
| Full Name | Dr John Brooke Tourtelot |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 34 Years |
| Location | 455 Pinellas St, Clearwater, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174577159 | NPI | - | NPPES |
| P00256492 | Other | FL | RAILROAD MEDICARE NUMBER |
| 269310100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | ME88865 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Josephs Hospital | Tampa, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc | 2264337021 | 920 |
News Archive
Oncotarget published "The pro-apoptotic actions of 2-methoxyestradiol against ovarian cancer involve catalytic activation of PKCδ signaling" which reported that the authors have previously shown that a flaxseed-supplemented diet decreases both the incidence and severity of ovarian cancer in laying hens, also induces CYP1A1 expression in liver.
Scientists have identified the main genetic switch that causes excessive mucous in the lungs, a discovery that one day could ease suffering for people with chronic lung diseases like asthma and cystic fibrosis, or just those fighting the common cold.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
Study results published in the May 17th issue of Circulation, the journal of the American Heart Association, found that the diabetes medication pioglitazone HCl reduced carotid artery intima-media thickness (IMT). Patients taking pioglitazone also experienced significant reductions in insulin resistance, C-reactive protein (a marker for inflammation) and blood pressure, all of which contribute to the overall risk for cardiovascular disease.
Many patients may soon find relief from the bloating, cramping, abdominal pain and constipation associated with irritable bowel syndrome, or IBS.
› Verified 5 days ago
| Entity Name | H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306833595 PECOS PAC ID: 2264337021 Enrollment ID: O20031204000575 |
News Archive
Oncotarget published "The pro-apoptotic actions of 2-methoxyestradiol against ovarian cancer involve catalytic activation of PKCδ signaling" which reported that the authors have previously shown that a flaxseed-supplemented diet decreases both the incidence and severity of ovarian cancer in laying hens, also induces CYP1A1 expression in liver.
Scientists have identified the main genetic switch that causes excessive mucous in the lungs, a discovery that one day could ease suffering for people with chronic lung diseases like asthma and cystic fibrosis, or just those fighting the common cold.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
Study results published in the May 17th issue of Circulation, the journal of the American Heart Association, found that the diabetes medication pioglitazone HCl reduced carotid artery intima-media thickness (IMT). Patients taking pioglitazone also experienced significant reductions in insulin resistance, C-reactive protein (a marker for inflammation) and blood pressure, all of which contribute to the overall risk for cardiovascular disease.
Many patients may soon find relief from the bloating, cramping, abdominal pain and constipation associated with irritable bowel syndrome, or IBS.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Brooke Tourtelot, MD Po Box 1698, Clearwater, FL 33757-1698 Ph: (727) 532-0002 | Dr John Brooke Tourtelot, MD 455 Pinellas St, Clearwater, FL 33756-3354 Ph: (727) 461-8300 |
News Archive
Oncotarget published "The pro-apoptotic actions of 2-methoxyestradiol against ovarian cancer involve catalytic activation of PKCδ signaling" which reported that the authors have previously shown that a flaxseed-supplemented diet decreases both the incidence and severity of ovarian cancer in laying hens, also induces CYP1A1 expression in liver.
Scientists have identified the main genetic switch that causes excessive mucous in the lungs, a discovery that one day could ease suffering for people with chronic lung diseases like asthma and cystic fibrosis, or just those fighting the common cold.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
Study results published in the May 17th issue of Circulation, the journal of the American Heart Association, found that the diabetes medication pioglitazone HCl reduced carotid artery intima-media thickness (IMT). Patients taking pioglitazone also experienced significant reductions in insulin resistance, C-reactive protein (a marker for inflammation) and blood pressure, all of which contribute to the overall risk for cardiovascular disease.
Many patients may soon find relief from the bloating, cramping, abdominal pain and constipation associated with irritable bowel syndrome, or IBS.
› Verified 5 days ago
Dr. David Scott Borislow, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 508 Jeffords St Ste D, Clearwater, FL 33756 Phone: 727-443-7700 Fax: 737-461-4379 | |
Dr. Irma Alves, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 300 Pinellas St, Clearwater, FL 33756 Phone: 727-462-7908 Fax: 727-462-7904 | |
Dr. Mark Alan Whiting, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 400 Pinellas St, Suite 350, Clearwater, FL 33756 Phone: 727-462-3696 Fax: 813-635-2637 | |
Dr. Steven Charles Bowman, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3251 N Mcmullen Booth Rd, Suite 303, Clearwater, FL 33761 Phone: 727-725-6110 Fax: 727-669-9742 | |
Dr. Mahesh Amin, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 455 Pinellas St Ste 330, Clearwater, FL 33756 Phone: 727-724-8611 Fax: 727-724-0425 | |
Dr. Sara Enid Cruz-luna, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1243 S Myrtle Ave, Clearwater, FL 33756 Phone: 727-442-3126 Fax: 727-287-4559 | |
Neisa I Diaz, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 13501 Icot Blvd Ste 114, Clearwater, FL 33760 Phone: 727-754-7880 Fax: 727-754-7885 |